Tselebis A, Koukkou E, Milionis C, Zabuliene L, Pachi A, Ilias I. Artificial night light and thyroid cancer. World J Methodol 2024; 14(1): 89853 [PMID: 38577208 DOI: 10.5662/wjm.v14.i1.89853]
Corresponding Author of This Article
Ioannis Ilias, MD, PhD, Consultant Physician-Scientist, Department of Endocrinology, Diabetes and Metabolism, Elena Venizelou General Hospital, 2 Elena Venizelou Square, Athens GR-11521, Greece. iiliasmd@yahoo.com
Research Domain of This Article
Endocrinology & Metabolism
Article-Type of This Article
Observational Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Athanasios Tselebis, Argyro Pachi, Department of Psychiatry, “Sotiria” General Chest Diseases Hospital, Athens GR-11527, Greece
Eftychia Koukkou, Charalampos Milionis, Ioannis Ilias, Department of Endocrinology, Diabetes and Metabolism, Elena Venizelou General Hospital, Athens GR-11521, Greece
Lina Zabuliene, Faculty of Medicine, Vilnius University, Vilnius LT-03101, Lithuania
Author contributions: Tselebis A and Ilias I designed this research work; Tselebis A, Koukkou E, Milionis C, Zabuliene L, Pachi A and Ilias I performed the research; Tselebis A and Ilias I analyzed the data; Tselebis A, Koukkou E, Milionis C, Zabuliene L, Pachi A and Ilias I wrote the paper; All authors have read and agreed to the published version of the manuscript.
Institutional review board statement: Since this work is based on available, anonymized epidemiological data no IRB approval was necessary.
Informed consent statement: Since this work was based on available anonymized epidemiological data no informed consent was required.
Conflict-of-interest statement: The authors report that they have no conflict of interest.
Data sharing statement: No additional data are available.
STROBE statement: The authors have read the STROBE Statement-checklist of items, and the manuscript was prepared and revised according to the STROBE Statement-checklist of items.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Ioannis Ilias, MD, PhD, Consultant Physician-Scientist, Department of Endocrinology, Diabetes and Metabolism, Elena Venizelou General Hospital, 2 Elena Venizelou Square, Athens GR-11521, Greece. iiliasmd@yahoo.com
Received: November 14, 2023 Peer-review started: November 14, 2023 First decision: November 30, 2023 Revised: December 6, 2023 Accepted: February 2, 2024 Article in press: February 2, 2024 Published online: March 20, 2024 Processing time: 113 Days and 17.8 Hours
Core Tip
Core Tip: We explored the impact of outdoor artificial light at night (ALN) on thyroid cancer (TC) worldwide. While a correlation was found between higher TC rates and ALN exposure in countries with greater economic indicators [gross domestic product (GDP) and health expenditure per person (HEP)], the association disappeared when accounting for registry quality. The findings suggest that high GDP may be more closely linked to health conditions and TC risk factors than ALN, possibly indicating a lifestyle connection to carcinogenesis. While correlations between ALN and economic factors are observed, a direct link of ALN to TC remains unconfirmed. Additionally, higher GDP/HEP could contribute to better diagnostic access, aiding TC diagnosis and registry inclusion.
